Defective interferon-gamma production in patients with hairy cell leukemia

Netherlands Journal of Medicine

Volumn 66, Issue 8, 2008, Pages 340-343

  Netea, M G ^a   Hoitink, O ^a   Kullberg, B J ^a   van der Meer, J W M ^a   Raymakers, R ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cytokines; Hairy cell leukemia; Interferon gamma; Mycobacteria

Indexed keywords

ALPHA INTERFERON; CLADRIBINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; CELL ISOLATION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HAIRY CELL LEUKEMIA; HUMAN; HUMAN CELL; INFECTION SENSITIVITY; INTERFERON PRODUCTION; MALE; MONONUCLEAR CELL; MYCOBACTERIOSIS; PROTEIN BLOOD LEVEL; SPLENECTOMY;

ADULT; CYTOKINES; FEMALE; HUMANS; INTERFERON TYPE II; LEUKEMIA, HAIRY CELL; MALE; MYCOBACTERIUM; PILOT PROJECTS;

EID: 54349094045     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Cawley JC, Burns GF and Hayhoe FJG. Hairy cell leukemia. Berlin: Springer-Verlag, 1980.
2. Bennett C, Vardiman J and Golomb H. Disseminated atypical mycobacterial infection in patients with hairy cell leukemia. Am J Med 1986;80:891-6.
3. Van der Meer JWM. Defects in host defense mechanisms. In: Rubin RH, Young LS, eds. Clinical approach to infection in the compromised host. New York: Plenum, 1994:33-66.
4. Kluin-Nelemans JC, Kester MG, Oving I, Cluitmans FH, Willemze R, Falkenburg JH. Abnormally activated T lymphocytes in the spleen of patients with hairy-cell leukemia. Leukemia 1994;8:2095-101.
5. Kluin-Nelemans HC, Kester MG, van de Corput L, et al. Correction of abnormal T-cell receptor repertoire during interferon-alpha therapy in patients with hairy cell leukemia. Blood 1998;91:4224-31.
6. Van de Corput L, Falkenburg JH, Kluin-Nelemans JC. T-cell dysfunction in hairy cell leukemia: an updated review. Leuk Lymphoma 1998;30:31-9
7. Van de Corput L, Falkenburg JH, Kester MG, Willemze R, Kluin-Nelemans JC. Impaired expression of CD28 on T cells in hairy cell leukemia. Clin Immunol 1999;93:256-62.
8. Ottenhof TH, Kumararatne D, Casanova JL. Novel human immunodeficiencies reveal the essential role of typed-I cytokines in immunity to intracellular bacteria. Immunol Today 1998;19:491-4.
9. Endres S, Ghorbani R, Lonnemann G, van der Meer JWM, Dinarello CA. Measurement of immunoreactive interleukin-1 beta from human mononuclear cells: optimization of recovery, intrasubject consistency, and comparison with interleukin-1 alpha and tumor necrosis factor. Clin Immunol Immunopathol 1988;49:424-38.
10. Foa R, Massaia M, Cardona S, et al. Production of tumor necrosis factor-alpha by B-cell chronic lymphocytic leukemia cells: a possible regulatory role of TNF in the progression of the disease. Blood 1990;76:393-400.
11. Eigler A, Waller-Fontaine K, Moeller J, Hartmann G, Hacker UT, Endres S. The hairy cell leukemia cell line Eskol spontaneously synthesizes tumor necrosis factor-alpha and nitric oxide. Leuk Res 1998;22:501-7.
12. De Jong R, Altare F, Haagen IA, et al. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 1998;280:1435-8.
13. Altare F, Durandy A, Lammas D, et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 1998;280:1432-5.
14. Orlikowsky T, Wang ZQ, Dudhane A, Horowitz H, Conti B, Hoffmann M. The cell surface marker phenotype of macrophages from HIV-1-infected subjects reflects an IL-10-Enriched and IFN-gamma-deprived donor environment. J Interferon Cytokine Res 1996;16:957-62.
15. Netea MG, Brouwer AE, Hoogendoorn EH, et al. Two patients with cryptococcal meningitis and idiopathic CD4 lymphopenia: defective cytokine production and reversal by recombinant interferon- gamma therapy. Clin Infect Dis 2004;39:e83-7.
16. Paganelli R, Scala E, Capobianchi MR, et al. Selective deficiency of interferon-gamma production in the hyper-IgE syndrome. Relationship to in vitro IgE synthesis. Clin Exp Immunol 1991;84:28-33.
17. Netea MG, Kullberg BJ, van der Meer JW. Severely impaired IL-12/IL-18/ IFNgamma axis in patients with hyper IgE syndrome. Eur J Clin Invest 2005;35:718-21
18. Grimbacher B, Holland SM, Gallin JI, et al. Hyper-IgE syndrome with recurrent infections - an autosomal dominant multisystern disorder. N Engl J Med 1999;340:692-702.
19. Van der Graaf CAA, Netea MG, Drenth JPH, te Morsche RH, van der Meer JWM, Kullberg BJ. Candida-specific interferon-gamma deficiency and Toll-like receptor polymorphisms in patients with chronic mucocutaneous candidiasis. Neth J Med 2003;61:365-9.
20. Netea MG, Radstake T, Joosten LA, van der Meer JWM, Kullberg BJ. Salmonella septicemia in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: association with decreased interferon-gamma production and Toll-like receptor 4 expression. Arthritis Rheum 2003;48:1853-7.